Primarily used as an intermediate in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs), this compound plays a crucial role in the development of medications aimed at reducing inflammation, pain, and fever. Its sulfamoyl group enhances its binding affinity to target enzymes, making it effective in inhibiting cyclooxygenase (COX) enzymes, which are responsible for producing prostaglandins that cause inflammation. Additionally, it is utilized in research settings to study the mechanisms of anti-inflammatory agents and to develop more efficient and safer therapeutic options. Its structural properties also make it a candidate for further chemical modifications to improve drug efficacy and reduce side effects.